Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 2017; Volume 91,Issue 1

Commentary

  • You have access
    Editor's Note
    Kathryn E. Meier
    Molecular Pharmacology January 2017, 91 (1) 74; DOI: https://doi.org/10.1124/mol.116.107961

Articles

  • You have access
    Novel Small Molecule JP-153 Targets the Src-FAK-Paxillin Signaling Complex to Inhibit VEGF-Induced Retinal Angiogenesis
    Jordan J. Toutounchian, Jayaprakash Pagadala, Duane D. Miller, Jerome Baudry, Frank Park, Edward Chaum and Charles R. Yates
    Molecular Pharmacology January 2017, 91 (1) 1-13; DOI: https://doi.org/10.1124/mol.116.105031
  • You have access
    Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance
    Hannah H. Lee, Brenda F. Leake, Richard B. Kim and Richard H. Ho
    Molecular Pharmacology January 2017, 91 (1) 14-24; DOI: https://doi.org/10.1124/mol.116.105544
  • Open Access
    Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics
    J. Daniel Hothersall, Dong Guo, Sunil Sarda, Robert J. Sheppard, Hongming Chen, Wesley Keur, Michael J. Waring, Adriaan P. IJzerman, Stephen J. Hill, Ian L. Dale and Philip B. Rawlins
    Molecular Pharmacology January 2017, 91 (1) 25-38; DOI: https://doi.org/10.1124/mol.116.105551
  • You have access
    Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets
    Matthew T. Duvernay, Kayla J. Temple, Jae G. Maeng, Anna L. Blobaum, Shaun R. Stauffer, Craig W. Lindsley and Heidi E. Hamm
    Molecular Pharmacology January 2017, 91 (1) 39-47; DOI: https://doi.org/10.1124/mol.116.106666
  • Open Access
    Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy
    Mandeep Atwal, Emma L. Lishman, Caroline A. Austin and Ian G. Cowell
    Molecular Pharmacology January 2017, 91 (1) 49-57; DOI: https://doi.org/10.1124/mol.116.106054
  • You have access
    Non-cell-autonomous Effects of Autophagy Inhibition in Tumor Cells Promote Growth of Drug-resistant Cells
    Jacqueline Thorburn, Leah Staskiewicz, Megan L. Goodall, Lina Dimberg, Arthur E. Frankel, Heide L. Ford and Andrew Thorburn
    Molecular Pharmacology January 2017, 91 (1) 58-64; DOI: https://doi.org/10.1124/mol.116.106070
  • You have access
    Endosomal Phosphatidylinositol 3-Kinase Is Essential for Canonical GPCR Signaling
    Yasunori Uchida, Florentine U. Rutaganira, Damien Jullié, Kevan M. Shokat and Mark von Zastrow
    Molecular Pharmacology January 2017, 91 (1) 65-73; DOI: https://doi.org/10.1124/mol.116.106252

Erratum

  • You have access
    Corrections to “The Follitropin Receptor: Matching Structure and Function”
    Molecular Pharmacology January 2017, 91 (1) 48; DOI: https://doi.org/10.1124/mol.111.104398err
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 91 (1)
Molecular Pharmacology
Vol. 91, Issue 1
1 Jan 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Commentary
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics